ATXN2 and Parkinson disease: Italian FTD study (n = 368) confirmed that intermediate repeats in ATXN2 are not associated with FTD but may modify the clinical features of the disease, e.g., younger age of onset, and increased presence of parkinsonism and psychotic symptoms at disease onset [50].